Multivariate analysis revealed that a combination of high expression of ATF6α and a low expression of phospho-P38 was associated with a poor outcome for PDAC patients (HR = 2.705; p = 0.023), together with tumour grade (HR = 2.886; p = 0.029) [91] (Table 1). This evidence concerns the gene ATF6 and neoplasm.